NCM
PFE icon

Northside Capital Management’s Pfizer PFE Stock Holding History

Northside Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,283
Closed -$233K – 196
2026
Q1 		$233K Hold
8,283
– – 0.02% 176
2025
Q4 		$206K Hold
8,283
– – 0.02% 191
2025
Q3 		$211K Hold
8,283
– – 0.02% 188
2025
Q2 		$201K Buy
+8,283
New +$193K 0.02% 185
2021
Q1 		– Sell
-6,724
Closed -$248K – 98
2020
Q4 		$248K Sell
6,724
-5,471
-45% -$201K 0.07% 76
2020
Q3 		$425K Hold
12,195
– – 0.14% 56
2020
Q2 		$378K Hold
12,195
– – 0.13% 68
2020
Q1 		$378K Hold
12,195
– – 0.18% 51
2019
Q4 		$453K Hold
12,195
– – 0.15% 59
2019
Q3 		$416K Sell
12,195
-2,926
-19% -$106K 0.15% 64
2019
Q2 		$621K Hold
15,121
– – 0.24% 38
2019
Q1 		$609K Buy
15,121
+854
+6% +$34.2K 0.24% 38
2018
Q4 		$591K Buy
14,267
+2,775
+24% +$115K 0.26% 37
2018
Q3 		$480K Sell
11,492
-411
-3% -$15.8K 0.17% 48
2018
Q2 		$410K Sell
11,903
-2,269
-16% -$77.5K 0.14% 50
2018
Q1 		$477K Buy
14,172
+354
+3% +$12.2K 0.16% 51
2017
Q4 		$475K Buy
13,818
+1,012
+8% +$34.5K 0.14% 51
2017
Q3 		$434K Buy
12,806
+906
+8% +$29.1K 0.18% 43
2017
Q2 		$379K Sell
11,900
-3,330
-22% -$105K 0.16% 45
2017
Q1 		$494K Buy
15,230
+732
+5% +$23.1K 0.14% 89
2016
Q4 		$447K Buy
14,498
+1,576
+12% +$48.1K 0.16% 43
2016
Q3 		$415K Buy
12,922
+1,022
+9% +$34.2K 0.16% 44
2016
Q2 		$398K Hold
11,900
– – 0.19% 42
2016
Q1 		$335K Buy
+11,900
New +$340K 0.21% 50

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northside Capital Management's PFE Position: Q2 2026 in Review

Northside Capital Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,283 shares — an estimated $233K sold.

Northside Capital Management first reported a position in PFE in Q1 2016 and held it in 24 quarters. The position peaked at $621K in Q2 2019. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Northside Capital Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Northside Capital Management sold 8,283 Pfizer shares in Q2 2026, an estimated $233K.
  • Northside Capital Management first reported a position in Pfizer in Q1 2016 and held it in 24 quarters.
  • Northside Capital Management's Pfizer position peaked at $621K in Q2 2019.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.